Similar articles for PMID: 30275207

Year	Number of Results
1950	1
1960	1
1986	2
1998	1
1999	1
2002	1
2003	2
2004	1
2005	2
2006	3
2007	2
2009	2
2010	2
2011	1
2012	2
2013	4
2014	3
2015	6
2016	9
2017	9
2018	2
2019	1
2020	6
2021	4
2022	1
2023	1

1

Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol.

Kenyon J, Liu W, Dalgleish A. Kenyon J, et al. Anticancer Res. 2018 Oct;38(10):5831-5835. doi: 10.21873/anticanres.12924. Anticancer Res. 2018. PMID: 30275207 Free article.

2

Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.

Fraguas-Sánchez AI, Fernández-Carballido A, Torres-Suárez AI. Fraguas-Sánchez AI, et al. Expert Opin Investig Drugs. 2016 Nov;25(11):1311-1323. doi: 10.1080/13543784.2016.1236913. Epub 2016 Sep 28. Expert Opin Investig Drugs. 2016. PMID: 27633508 Review.

3

Cannabidiol: an alternative therapeutic agent for oral mucositis?

Cuba LF, Salum FG, Cherubini K, Figueiredo MAZ. Cuba LF, et al. J Clin Pharm Ther. 2017 Jun;42(3):245-250. doi: 10.1111/jcpt.12504. Epub 2017 Feb 12. J Clin Pharm Ther. 2017. PMID: 28191662 Review.

4

Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines.

Massi P, Vaccani A, Ceruti S, Colombo A, Abbracchio MP, Parolaro D. Massi P, et al. J Pharmacol Exp Ther. 2004 Mar;308(3):838-45. doi: 10.1124/jpet.103.061002. Epub 2003 Nov 14. J Pharmacol Exp Ther. 2004. PMID: 14617682

5

Anti-proliferative and cytotoxic effect of cannabidiol on human cancer cell lines in presence of serum.

Sainz-Cort A, Müller-Sánchez C, Espel E. Sainz-Cort A, et al. BMC Res Notes. 2020 Aug 20;13(1):389. doi: 10.1186/s13104-020-05229-5. BMC Res Notes. 2020. PMID: 32819436 Free PMC article.

6

Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.

Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L, Laezza C, Portella G, Bifulco M, Di Marzo V. Ligresti A, et al. J Pharmacol Exp Ther. 2006 Sep;318(3):1375-87. doi: 10.1124/jpet.106.105247. Epub 2006 May 25. J Pharmacol Exp Ther. 2006. PMID: 16728591

7

Delta(9) -tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature.

Fowler CJ. Fowler CJ. Clin Pharmacol Ther. 2015 Jun;97(6):587-96. doi: 10.1002/cpt.84. Epub 2015 May 2. Clin Pharmacol Ther. 2015. PMID: 25669486 Review.

8

Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome.

Reuter SE, Martin JH. Reuter SE, et al. Clin Pharmacokinet. 2016 Jul;55(7):807-812. doi: 10.1007/s40262-015-0363-2. Clin Pharmacokinet. 2016. PMID: 26883879 Review.

9

From Cannabis to Cannabidiol to Treat Epilepsy, Where Are We?

Lippiello P, Balestrini S, Leo A, Coppola A, Citraro R, Elia M, Russo E, De Sarro G. Lippiello P, et al. Curr Pharm Des. 2016;22(42):6426-6433. doi: 10.2174/1381612822666160831122722. Curr Pharm Des. 2016. PMID: 27587196 Review.

10

discovering new anticancer activities from old drugs.

Wu E. Wu E. Curr Med Chem. 2013;20(33):4093-4. doi: 10.2174/09298673113209990193. Curr Med Chem. 2013. PMID: 23895683 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

58 results

Results by year